BackAnthera Pharmaceuticals Overview

Anthera Pharmaceuticals Operating Income

Operating Income for ANTH.

Quarterly Operating Income

$-10971000.00
↑ 3.46% YoY

As of Mar 31, 2018

Annual Operating Income (TTM)

$-36799000.00
↓ 34.36% YoY

Trailing 12 months ending Mar 31, 2018

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin